| Substance Abuse, Volume 41, 2020 is now available online on Taylor & Francis Online. Here are the articles that are published in this volume: |
Editorial
Abstracts from the 2019 Annual Meeting of the International Society of Addiction Medicine (ISAM) in New Delhi, India and a thank you to the 2019 peer reviewers of Substance Abuse
Adam J. Gordon MD MPH
Pages: 1-2 | DOI: 10.1080/08897077.2020.1730140
Letters to the Editor
Out damn bot, out: Recruiting real people into substance use studies on the internet
Alexandra Godinho MScCH, Christina Schell BSc & John A. Cunningham PhD
Pages: 3-5 | DOI: 10.1080/08897077.2019.1691131
Persisting gaps in M-OUD coverage at post-discharge recovery houses necessitate our continued advocacy
Pious Patel BA, Rahul Ramaswamy BS & Ramzi Mardam Bey MD MSc
Pages: 11-13 | DOI: 10.1080/08897077.2019.1695038
Commentary
Women and substance use disorders in low- and middle-income countries: A call for advancing research equity in prevention and treatment
Ilze Slabbert PhD, M. Claire Greene PhD, Jacqueline S. Womersley PhD, Oladiran I. Olateju PhD, Matiwos Soboka MSc & Andrine M. Lemieux PhD
Pages: 6-10 | DOI: 10.1080/08897077.2019.1680481
Brief Reports
Educational lectures enhance knowledge about the human immunodeficiency virus (HIV) and reduce risky behavior and fear among methadone maintenance treatment patients
Idan Barak MA, Miriam Adelson MD, Anat Sason MA, Yuval Livnat PhD, Shaul Schreiber MD & Einat Peles PhD
Pages: 14-18 | DOI: 10.1080/08897077.2018.1528492
Examination of a group entry model into alcohol and other drug (AOD) treatment: Improvements in attendance, retention, and clinical capacity
Kim Sander BSocWork, Hollie Wilson PhD, John Kelly BA(Psych), Post Grad Dip Psych & Anthony Bligh MPsych(Clin)
Pages: 19-23 | DOI: 10.1080/08897077.2019.1635064
Opioid use patterns and risk characteristics among injured patients
Gerald Cochran PhD, Maria L. Pacella PhD, Whitney Ringwald CADC, MSW, Melissa Repine MS, Valerie Hruschak MSW, ABD, Corinne Beaugard MSW, Craig Sewall MSW, LCSW, Danny Rosen PhD, Louis H. Alarcon MD, FACS, FCCM, Ivan S. Tarkin MD, Gele B. Moloney MD & Alain Corcos MD, FACS
Pages: 24-28 | DOI: 10.1080/08897077.2019.1635065
Opioid overdose prevention education for medical students: Adopting harm reduction into mandatory clerkship curricula
Benjamin J. Oldfield MD, MHS, Jeanette M. Tetrault MD, Kirsten M. Wilkins MD, E. Jennifer Edelman MD, MHS & Noah A. Capurso MD, MHS
Pages: 29-34 | DOI: 10.1080/08897077.2019.1621241
Review Article
The opioid and related drug epidemics in rural Appalachia: A systematic review of populations affected, risk factors, and infectious diseases
Christine A. Schalkoff MSPH, Kathryn E. Lancaster PhD, MPH, Bradley N. Gaynes MD, MPH, Vivian Wang BS, Brian W. Pence PhD, William C. Miller MD, PhD, MPH & Vivian F. Go PhD, MPH
Pages: 35-69 | DOI: 10.1080/08897077.2019.1635555
Original Research
Housing versus treatment first for supportive housing participants with substance use disorders: A comparison of housing and public service use outcomes
Gerod Hall PhD, MPH, Sarah Walters MPH, Hannah Gould PhD, MBA & Sungwoo Lim MS, DrPH
Pages: 70-76 | DOI: 10.1080/08897077.2018.1449049
Psychiatric comorbidity and co-occurring opioid misuse: Depression mediates the relationship between post-traumatic stress disorder and opioid misuse in community pharmacy settings
Valerie Hruschak PhD, MSW, Aimee K. Hildenbrand PhD & Gerald Cochran MSW, PhD
Pages: 77-84 | DOI: 10.1080/08897077.2019.1621238
Does the perceived accuracy of urine drug testing impact clinical decision-making?
Barry Rosenfeld PhD, David V. Budescu PhD, Ying Han MA, Melodie Foellmi PhD, Kenneth L. Kirsh PhD & Steven D. Passik PhD
Pages: 85-92 | DOI: 10.1080/08897077.2019.1621239
Friends and relatives as sources of prescription opioids for misuse among young adults: The significance of physician source and race/ethnic differences
Jason A. Ford PhD, Corey Pomykacz MA, Alec Szalewski MA, Sean Esteban McCabe PhD & Ty S. Schepis PhD
Pages: 93-100 | DOI: 10.1080/08897077.2019.1635955
Impact of academic detailing on benzodiazepine use among veterans with posttraumatic stress disorder
Mark Bounthavong PharmD, PhD, Marcos K. Lau PharmD, MS, Sarah J. Popish PharmD, Chad L. Kay PharmD, Daina L. Wells PharmD, Julianne E. Himstreet PharmD, Michael A. Harvey PharmD & Melissa L. D. Christopher PharmD
Pages: 101-109 | DOI: 10.1080/08897077.2019.1573777
Initiating opioid agonist treatment for opioid use disorder nationally in the Veterans Health Administration: Who gets what?
Ajay Manhapra MD, Elina Stefanovics PhD & Robert Rosenheck MD
Pages: 110-120 | DOI: 10.1080/08897077.2019.1640831
Provider–patient communication about prescription drug abuse: A qualitative analysis of the perspective of prescribers
Stephanie M. Mathis DrPH, MPH, Angela Hagaman MA, LPCA, Nicholas Hagemeier PharmD, PhD, Katie Baker DrPH, MPH & Robert P. Pack PhD, MPH
Pages: 121-131 | DOI: 10.1080/08897077.2019.1635956
The relationship between negative trauma-related cognitions and psychosocial functioning in veterans with posttraumatic stress disorder and alcohol use disorder
Robert Lyons BS, Moira Haller PhD, Inga Curry PhD & Sonya B. Norman PhD
Pages: 132-138 | DOI: 10.1080/08897077.2019.1635957
Health care engagement behaviors of men who use performance- and image-enhancing drugs in Australia
B. Jacka PhD, B. Larance PhD, J. Copeland PhD, L. Burns PhD, M. Farrell FRCP FRCPsych, E. Jackson MBBS, FAChSHM & L. Degenhardt PhD
Pages: 139-145 | DOI: 10.1080/08897077.2019.1635954